A role for vaccinia virus protein C16 in reprogramming cellular energy metabolism

Journal of General Virology

Volumn 96, Issue 2, 2015, Pages 395-407

  Mazzon, Michela ^a,d   Castro, Cecilia ^b   Roberts, Lee D ^b,c   Griffin, Julian L ^b,c   Smith, Geoffrey L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE DERIVATIVE; UNCLASSIFIED DRUG; VACCINIA VIRUS PROTEIN C16; VIRUS PROTEIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

AMINO ACID METABOLISM; ARTICLE; CELL ENERGY; CELL METABOLISM; FEMALE; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR REPROGRAMMING; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; VACCINIA VIRUS; VIRUS INFECTION; CELL LINE; ENERGY METABOLISM; GENE DELETION; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PROTEIN STABILITY;

DNA VIRUSES; VACCINIA VIRUS;

CELL LINE; ENERGY METABOLISM; GENE DELETION; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PROTEIN STABILITY; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 84921816433     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.069591-0     Document Type: Article

References (64)

1. Banham, A. H. & Smith, G. L. (1992). Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions. Virology 191, 803-812.
2. Broyles, S. S. (1993). Vaccinia virus encodes a functional dUTPase. Virology 195, 863-865.
3. Buller, R. M., Chakrabarti, S., Moss, B. & Fredrickson, T. (1988a). Cell proliferative response to vaccinia virus is mediated by VGF. Virology 164, 182-192.
4. Buller, R. M., Chakrabarti, S., Cooper, J. A., Twardzik, D. R. & Moss, B. (1988b). Deletion of the vaccinia virus growth factor gene reduces virus virulence. J Virol 62, 866-874.
5. Carroll, P. A., Kenerson, H. L., Yeung, R. S. & Lagunoff, M. (2006). Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors. J Virol 80, 10802-10812.
6. Chen, J. Q. & Russo, J. (2012). Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim Biophys Acta 1826, 370-384.
7. Colinas, R. J., Goebel, S. J., Davis, S. W., Johnson, G. P., Norton, E. K. & Paoletti, E. (1990). A DNA ligase gene in the Copenhagen strain of vaccinia virus is nonessential for viral replication and recombination. Virology 179, 267-275.
8. Darekar, S., Georgiou, K., Yurchenko, M., Yenamandra, S. P., Chachami, G., Simos, G., Klein, G. & Kashuba, E. (2012). Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect. PLoS ONE 7, e42072.
9. Daye, D. & Wellen, K. E. (2012). Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis. Semin Cell Dev Biol 23, 362-369.
10. De Silva, F. S. & Moss, B. (2003). Vaccinia virus uracil DNA glycosylase has an essential role in DNA synthesis that is independent of its glycosylase activity: catalytic site mutations reduce virulence but not virus replication in cultured cells. J Virol 77, 159-166.
11. De Silva, F. S. & Moss, B. (2008). Effects of vaccinia virus uracil DNA glycosylase catalytic site and deoxyuridine triphosphatase deletion mutations individually and together on replication in active and quiescent cells and pathogenesis in mice. Virol J 5, 145.
12. Diamond, D. L., Syder, A. J., Jacobs, J. M., Sorensen, C. M., Walters, K. A., Proll, S. C., McDermott, J. E., Gritsenko, M. A., Zhang, Q. & other authors (2010). Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog 6, e1000719.
13. Fahy, A. S., Clark, R. H., Glyde, E. F. & Smith, G. L. (2008). Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. J Gen Virol 89, 2377-2387.
14. Fenner, F., Anderson, D. A., Arita, I., Jezek, Z. & Ladnyi, I. D. (1988). Smallpox and Its Eradication. Geneva: World Health Organization.
15. Ferguson, B. J., Mansur, D. S., Peters, N. E., Ren, H. & Smith, G. L. (2012). DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. elife 1, e00047.
16. Filipp, F. V., Scott, D. A., Ronai, Z. A., Osterman, A. L. & Smith, J. W. (2012). Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells. Pigment Cell Melanoma Res 25, 375-383.
17. Fontaine, K. A., Camarda, R. & Lagunoff, M. (2014). Vaccinia virus requires glutamine but not glucose for efficient replication. J Virol 88, 4366-4374.
18. Goebel, S. J., Johnson, G. P., Perkus, M. E., Davis, S. W., Winslow, J. P. & Paoletti, E. (1990). The complete DNA sequence of vaccinia virus. Virology 179, 247-266, 517-563.
19. Greseth, M. D. & Traktman, P. (2014). De novo fatty acid biosynthesis contributes significantly to establishment of a bioenergetically favorable environment for vaccinia virus infection. PLoS Pathog 10, e1004021.
20. Guan, K. L., Broyles, S. S. & Dixon, J. E. (1991). A Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature 350, 359-362.
21. Guerra, S., López-Fernández, L. A., Pascual-Montano, A., Muñoz, M., Harshman, K. & Esteban, M. (2003). Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J Virol 77, 6493-6506.
22. Heaton, N. S., Perera, R., Berger, K. L., Khadka, S., Lacount, D. J., Kuhn, R. J. & Randall, G. (2010). Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci U S A 107, 17345-17350.
23. Hruby, D. E. & Ball, L. A. (1982). Mapping and identification of the vaccinia virus thymidine kinase gene. J Virol 43, 403-409.
24. Hughes, S. J., Johnston, L. H., de Carlos, A. & Smith, G. L. (1991). Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. J Biol Chem 266, 20103-20109.
25. Joklik, W. K. & Becker, Y. (1964). The replication and coating of vaccinia DNA. J Mol Biol 10, 452-474.
26. Jones, E. V. & Moss, B. (1984). Mapping of the vaccinia virus DNA polymerase gene by marker rescue and cell-free translation of selected RNA. J Virol 49, 72-77.
27. Kerr, S. M. & Smith, G. L. (1989). Vaccinia virus encodes a polypeptide with DNA ligase activity. Nucleic Acids Res 17, 9039-9050.
28. Lin, S. & Broyles, S. S. (1994). Vaccinia protein kinase 2: a second essential serine/threonine protein kinase encoded by vaccinia virus. Proc Natl Acad Sci U S A 91, 7653-7657.
29. Lin, S., Chen, W. & Broyles, S. S. (1992). The vaccinia virus B1R gene product is a serine/threonine protein kinase. J Virol 66, 2717-2723.
30. Martin, F. P., Dumas, M. E., Wang, Y., Legido-Quigley, C., Yap, I. K., Tang, H., Zirah, S., Murphy, G. M., Cloarec, O. & other authors (2007). A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol 3, 112.
31. Mazzon, M., Peters, N. E., Loenarz, C., Krysztofinska, E. M., Ember, S. W., Ferguson, B. J. & Smith, G. L. (2013). A mechanism for induction of a hypoxic response by vaccinia virus. Proc Natl Acad Sci U S A 110, 12444-12449.
32. McFarlane, S., Nicholl, M. J., Sutherland, J. S. & Preston, C. M. (2011). Interaction of the human cytomegalovirus particle with the host cell induces hypoxia-inducible factor 1 alpha. Virology 414, 83-90.
33. McGeoch, D. J. (1990). Protein sequence comparisons show that the 'pseudoproteases' encoded by poxviruses and certain retroviruses belong to the deoxyuridine triphosphatase family. Nucleic Acids Res 18, 4105-4110.
34. Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J. & other authors (2012). Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481, 380-384.
35. Moore, J. B. & Smith, G. L. (1992). Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor. EMBO J 11, 1973-1980.
36. Moss, B. (2007). Poxviridae: the viruses and their replicaton. In Fields Virology, 5th edn, vol. 2, pp. 2905-2946. Edited by D. M. Knipe. Philadelphia, PA: Lippincott Williams & Wilkins.
37. Moss, B. (2013). Poxvirus DNA replication. Cold Spring Harb Perspect Biol 5, a010199.
38. Mucaj, V., Shay, J. E. & Simon, M. C. (2012). Effects of hypoxia and HIFs on cancer metabolism. Int J Hematol 95, 464-470.
39. Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P. H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S. & DeBerardinis, R. J. (2012). Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481, 385-388.
40. Nakamura, M., Bodily, J. M., Beglin, M., Kyo, S., Inoue, M. & Laimins, L. A. (2009). Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses. Virology 387, 442-448.
41. Nasimuzzaman, M., Waris, G., Mikolon, D., Stupack, D. G. & Siddiqui, A. (2007). Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J Virol 81, 10249-10257.
42. Peters, N. E., Ferguson, B. J., Mazzon, M., Fahy, A. S., Krysztofinska, E., Arribas-Bosacoma, R., Pearl, L. H., Ren, H. & Smith, G. L. (2013). A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog 9, e1003649.
43. Reading, P. C., Moore, J. B. & Smith, G. L. (2003). Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infection. J Exp Med 197, 1269-1278.
44. Rempel, R. E. & Traktman, P. (1992). Vaccinia virus B1 kinase: phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins. J Virol 66, 4413-4426.
45. Roberts, L. D., Souza, A. L., Gerszten, R. E. & Clish, C. B. (2012). Targeted metabolomics. Curr Protoc Mol Biol 98, 30. 2. 1-30. 2. 24.
46. Semenza, G. L. (2012). Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408.
47. Senkevich, T. G., White, C. L., Koonin, E. V. & Moss, B. (2002). Complete pathway for protein disulfide bond formation encoded by poxviruses. Proc Natl Acad Sci U S A 99, 6667-6672.
48. Shuman, S. & Moss, B. (1987). Identification of a vaccinia virus gene encoding a type I DNA topoisomerase. Proc Natl Acad Sci U S A 84, 7478-7482.
49. Slabaugh, M., Roseman, N., Davis, R. & Mathews, C. (1988). Vaccinia virus-encoded ribonucleotide reductase: sequence conservation of the gene for the small subunit and its amplification in hydroxyurearesistant mutants. J Virol 62, 519-527.
50. Smith, G. L., Chan, Y. S. & Kerr, S. M. (1989a). Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases. Nucleic Acids Res 17, 9051-9062.
51. Smith, G. L., de Carlos, A. & Chan, Y. S. (1989b). Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping. Nucleic Acids Res 17, 7581-7590.
52. Smith, G. L., Benfield, C. T., Maluquer de Motes, C., Mazzon, M., Ember, S. W., Ferguson, B. J. & Sumner, R. P. (2013). Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 94, 2367-2392.
53. Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W., Fiehn, O., Goodacre, R. & other authors (2007). Proposed minimum reporting standards for chemical analysis: Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3, 211-221.
54. Sun, R. C. & Denko, N. C. (2014). Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth. Cell Metab 19, 285-292.
55. Tang, X., Zhang, Q., Nishitani, J., Brown, J., Shi, S. & Le, A. D. (2007). Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin Cancer Res 13, 2568-2576.
56. Tengelsen, L. A., Slabaugh, M. B., Bibler, J. K. & Hruby, D. E. (1988). Nucleotide sequence and molecular genetic analysis of the large subunit of ribonucleotide reductase encoded by vaccinia virus. Virology 164, 121-131.
57. Twardzik, D. R., Brown, J. P., Ranchalis, J. E., Todaro, G. J. & Moss, B. (1985). Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors. Proc Natl Acad Sci U S A 82, 5300-5304.
58. van der Werf, M., Takors, R., Smedsgaard, J., Nielsen, J., Ferenci, T., Portais, J., Wittmann, C., Hooks, M., Tomassini, A. & other authors (2007). Standard reporting requirements for biological samples in metabolomics experiments: microbial and in vitro biology experiments. Metabolomics 3, 189-194.
59. Vastag, L., Koyuncu, E., Grady, S. L., Shenk, T. E. & Rabinowitz, J. D. (2011). Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog 7, e1002124.
60. Weir, J. P., Bajszár, G. & Moss, B. (1982). Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA. Proc Natl Acad Sci U S A 79, 1210-1214.
61. Werth, N., Beerlage, C., Rosenberger, C., Yazdi, A. S., Edelmann, M., Amr, A., Bernhardt, W., von Eiff, C., Becker, K. & other authors (2010). Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS ONE 5, e11576.
62. White, C. L., Weisberg, A. S. & Moss, B. (2000). A glutaredoxin, encoded by the G4L gene of vaccinia virus, is essential for virion morphogenesis. J Virol 74, 9175-9183.
63. Wise, D. R., Ward, P. S., Shay, J. E., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C. & Thompson, C. B. (2011). Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of a-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A 108, 19611-19616.
64. Yu, Y., Clippinger, A. J. & Alwine, J. C. (2011). Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection. Trends Microbiol 19, 360-367.